• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Biohaven Leaps After Posting $93M Sales for Migraine Drug

cafead

Administrator
Staff member
  • cafead   Jul 07, 2021 at 12:12: PM
via Biohaven's Nurtec was approved for migraine treatment in February 2020 and for prevention this past May. Q2 sales: $93 million.

article source